Jubilant Ingrevia Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹489.2
- Today's High:
- ₹519.3
- Open Price:
- ₹512.7
- 52W Low:
- ₹350.8
- 52W High:
- ₹592.45
- Prev. Close:
- ₹513.8
- Volume:
- 24723
Company Statistics
- Market Cap.:
- ₹66.34 billion
- Book Value:
- 167.691
- Revenue TTM:
- ₹47.73 billion
- Operating Margin TTM:
- 8.9%
- Gross Profit TTM:
- ₹15.15 billion
- Profit Margin:
- 6.44%
- Return on Assets TTM:
- 6.59%
- Return on Equity TTM:
- 12.06%
Company Profile
Jubilant Ingrevia Ltd had its IPO on under the ticker symbol JUBLINGREA.
The company operates in the Healthcare sector and Biotechnology industry. Jubilant Ingrevia Ltd has a staff strength of 0 employees.
Stock update
Shares of Jubilant Ingrevia Ltd opened at ₹512.7 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹489.2 - ₹519.3, and closed at ₹497.
This is a -3.27% slip from the previous day's closing price.
A total volume of 24,723 shares were traded at the close of the day’s session.
In the last one week, shares of Jubilant Ingrevia Ltd have slipped by -2.63%.
Jubilant Ingrevia Ltd's Key Ratios
Jubilant Ingrevia Ltd has a market cap of ₹66.34 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Jubilant Ingrevia Ltd’s revenue was ₹47.73 billion with a gross profit of ₹15.15 billion and an EBITDA of ₹5.47 billion. The EBITDA ratio measures Jubilant Ingrevia Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Jubilant Ingrevia Ltd’s operating margin was 8.9% while its return on assets stood at 6.59% with a return of equity of 12.06%.
In Q1, Jubilant Ingrevia Ltd’s quarterly earnings growth was a negative -23.5% while revenue growth was a negative 11.6%.
Jubilant Ingrevia Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 21.1421
- PEG
Its diluted EPS in the last 12-months stands at ₹19.7 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Jubilant Ingrevia Ltd’s profitability.
Jubilant Ingrevia Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Jubilant Ingrevia Ltd stock pays annual dividends of ₹5 per share, indicating a yield of 1.21% and a payout ratio of 15.6%.
Balance sheet and cash flow metrics
- Total Assets
- ₹42.59 billion
- Total Liabilities
- ₹11.80 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 15.6%
Jubilant Ingrevia Ltd ended 2024 with ₹42.59 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹42.59 billion while shareholder equity stood at ₹26.66 billion.
Jubilant Ingrevia Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹11.80 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹727.30 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹1.50 billion.
Jubilant Ingrevia Ltd’s total current assets stands at ₹18.18 billion while long-term investments were ₹0 and short-term investments were ₹348.20 million. Its net receivables were ₹5.11 billion compared to accounts payable of ₹8.01 billion and inventory worth ₹10.35 billion.
In 2024, Jubilant Ingrevia Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Jubilant Ingrevia Ltd paid ₹0.16 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹497
- 52-Week High
- ₹592.45
- 52-Week Low
- ₹350.8
- Analyst Target Price
- ₹
Jubilant Ingrevia Ltd stock is currently trading at ₹497 per share. It touched a 52-week high of ₹592.45 and a 52-week low of ₹592.45. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹445.39 and 200-day moving average was ₹449.57 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5711.1% of the company’s stock are held by insiders while 1028.2% are held by institutions.
Frequently Asked Questions About Jubilant Ingrevia Ltd
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.